[A phase-I clinical trial of a new antitetanus/antidiphtheria vaccine for adults].
Podda
A
A
BIOCINE SCLAVO SpA, Siena.
Vescia
N
N
Donati
D
D
Marsili
I
I
Volpini
G
G
Nencioni
L
L
Mastroeni
I
I
Rappuoli
R
R
Fara
G M
GM
D000293:Adolescent; D000907:Antibodies, Bacterial / Q000097:blood; D001426:Bacterial Proteins / Q000009:adverse effects / Q000276:immunology; D003017:Clostridium tetani / Q000276:immunology; D003353:Corynebacterium diphtheriae / Q000276:immunology; D004168:Diphtheria Toxoid / Q000009:adverse effects / Q000276:immunology*; D022422:Diphtheria-Tetanus Vaccine; D004338:Drug Combinations; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013745:Tetanus Toxoid / Q000009:adverse effects / Q000276:immunology*
D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D004168:Diphtheria Toxoid; D022422:Diphtheria-Tetanus Vaccine; D004338:Drug Combinations; D013745:Tetanus Toxoid; C028581:CRM197 (non-toxic variant of diphtheria toxin)
Valutazione clinica di fase I di un nuovo vaccino antitetanico/antidifterico per adulti.